144 related articles for article (PubMed ID: 15803357)
1. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk.
Langsenlehner U; Krippl P; Renner W; Yazdani-Biuki B; Eder T; Köppel H; Wascher TC; Paulweber B; Samonigg H
Breast Cancer Res Treat; 2005 Mar; 90(2):113-5. PubMed ID: 15803357
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study.
Eder T; Mayer R; Langsenlehner U; Renner W; Krippl P; Wascher TC; Pummer K; Kapp KS
Eur J Cancer; 2007 Feb; 43(3):472-5. PubMed ID: 17182240
[TBL] [Abstract][Full Text] [Related]
3. Haplotype-tagging interleukin-10 promoter polymorphism is associated with reduced risk of retinal artery occlusion.
Weger M; Steinbrugger I; El-Shabrawi Y; Wegscheider BJ; Weger W; Renner W; Schmut O; Haas A
Mol Vis; 2007 Apr; 13():549-52. PubMed ID: 17438520
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
Wei YS; Kuang XH; Zhu YH; Liang WB; Yang ZH; Tai SH; Zhao Y; Zhang L
Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study.
Langsenlehner U; Wolf G; Langsenlehner T; Gerger A; Hofmann G; Clar H; Wascher TC; Paulweber B; Samonigg H; Krippl P; Renner W
Breast Cancer Res Treat; 2008 May; 109(2):297-304. PubMed ID: 17636397
[TBL] [Abstract][Full Text] [Related]
6. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.
Kataoka N; Cai Q; Wen W; Shu XO; Jin F; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1148-52. PubMed ID: 16775174
[TBL] [Abstract][Full Text] [Related]
7. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Köppel H; Leithner A; Wascher TC; Paulweber B; Samonigg H
Clin Cancer Res; 2004 May; 10(10):3518-20. PubMed ID: 15161710
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients.
Ezzidi I; Mtiraoui N; Kacem M; Mallat SG; Mohamed MB; Chaieb M; Mahjoub T; Almawi WY
Clin Endocrinol (Oxf); 2009 Mar; 70(3):401-7. PubMed ID: 18616700
[TBL] [Abstract][Full Text] [Related]
9. Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.
Langsenlehner U; Renner W; Yazdani-Biuki B; Eder T; Wascher TC; Paulweber B; Clar H; Hofmann G; Samonigg H; Krippl P
Breast Cancer Res Treat; 2006 May; 97(1):67-72. PubMed ID: 16317580
[TBL] [Abstract][Full Text] [Related]
10. Association of -592C/A, -819C/T and -1082A/G interleukin-10 promoter polymorphisms with idiopathic recurrent spontaneous abortion.
Zammiti W; Mtiraoui N; Cochery-Nouvellon E; Mahjoub T; Almawi WY; Gris JC
Mol Hum Reprod; 2006 Dec; 12(12):771-6. PubMed ID: 17041236
[TBL] [Abstract][Full Text] [Related]
11. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in interleukin-10 gene and risk of oral cancer.
Yao JG; Gao LB; Liu YG; Li J; Pang GF
Clin Chim Acta; 2008 Feb; 388(1-2):84-8. PubMed ID: 17980158
[TBL] [Abstract][Full Text] [Related]
13. A novel single nucleotide polymorphism of the cyclooxygenase-2 gene associated with breast cancer.
Li F; Ren GS; Li HY; Wang XY; Chen L; Li J
Clin Oncol (R Coll Radiol); 2009 May; 21(4):302-5. PubMed ID: 19138835
[TBL] [Abstract][Full Text] [Related]
14. Association of breast cancer and cytokine gene polymorphism in Turkish women.
Gonullu G; Basturk B; Evrensel T; Oral B; Gozkaman A; Manavoglu O
Saudi Med J; 2007 Nov; 28(11):1728-33. PubMed ID: 17965799
[TBL] [Abstract][Full Text] [Related]
15. Caspase 9 promoter polymorphisms and risk of primary lung cancer.
Park JY; Park JM; Jang JS; Choi JE; Kim KM; Cha SI; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Lee JT; Jung TH
Hum Mol Genet; 2006 Jun; 15(12):1963-71. PubMed ID: 16687442
[TBL] [Abstract][Full Text] [Related]
16. Role of IL-10 promoter polymorphisms in the development of severe aorto-iliac occlusive disease.
Blanco E; Moñux G; Mas A; Serrano FJ; de la Concha EG; Urcelay E
Hum Immunol; 2008 Oct; 69(10):651-4. PubMed ID: 18703105
[TBL] [Abstract][Full Text] [Related]
17. Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Hum Immunol; 2008 Mar; 69(3):179-86. PubMed ID: 18396210
[TBL] [Abstract][Full Text] [Related]
18. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC
Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010
[TBL] [Abstract][Full Text] [Related]
19. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands.
Rosado S; Rua-Figueroa I; Vargas JA; Garcia-Laorden MI; Losada-Fernandez I; Martin-Donaire T; Perez-Chacon G; Rodriguez-Gallego C; Naranjo-Hernandez A; Ojeda-Bruno S; Citores MJ; Perez-Aciego P
Int J Immunogenet; 2008 Jun; 35(3):235-42. PubMed ID: 18397303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
